Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genital Diseases, Female”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05817214
What this trial is testing

Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer

Who this might be right for
Cervical Cancer
Zhongnan Hospital 35
Not applicableLooking for participantsNCT07816133
What this trial is testing

Study on the Ultrasound and Biological Characteristics of Atypical Endometriosis.

Who this might be right for
Endometriosis
Casa di Cura Dott. Pederzoli 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554328
What this trial is testing

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+1 more
National Cancer Institute (NCI) 165
Not applicableActive Not RecruitingNCT03045965
What this trial is testing

Hysterectomy and OPPortunistic SAlpingectomy

Who this might be right for
Ovarian CancerComplication
Göteborg University 4,400
Testing effectiveness (Phase 2)Study completedNCT00014599
What this trial is testing

Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva

Who this might be right for
Vulvar Cancer
European Organisation for Research and Treatment of Cancer - EORTC 31
Not applicableUnknownNCT01289314
What this trial is testing

Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy

Who this might be right for
Total Laparoscopic HysterectomyLaparoscopic Supracervical HysterectomyFibromas+2 more
Oslo University Hospital 62
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Large-scale testing (Phase 3)Active Not RecruitingNCT06746116
What this trial is testing

Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain

Who this might be right for
Advanced or Recurrent Endometrial Cancer
AstraZeneca 45
Not applicableNot Yet RecruitingNCT07540962
What this trial is testing

The Effect Of Motıvatıonal Intervıewıng On Cancer Fear And Partıcıpatıon In Cervıcal Cancer Screenıngs Among Women Lıvıng In Rural Areas

Who this might be right for
Fear
Ozge Aslan Koyutürk 80
Large-scale testing (Phase 3)Looking for participantsNCT06817161
What this trial is testing

Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:

Who this might be right for
Ovarian CarcinomaFirst Line ChemotherapyDigestive System Disorders
Centre Francois Baclesse 116
Testing effectiveness (Phase 2)Study completedNCT00529542
What this trial is testing

A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Polycystic Ovary Syndrome
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT04903873
What this trial is testing

Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more
Eutilex 110
Testing effectiveness (Phase 2)Ended earlyNCT03302156
What this trial is testing

PSMA PET and MRI in Gynecological Cancers

Who this might be right for
Gynecologic Cancer
University of Wisconsin, Madison 15
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Not applicableStudy completedNCT03049332
What this trial is testing

Self- and Family-management Intervention in HIV+ Chinese Women

Who this might be right for
Hiv
Yale University 82
Not applicableStudy completedNCT04245293
What this trial is testing

Clinical Trial Study To Evaluate The Performance And Safety Of Ainara®

Who this might be right for
Vaginal Disease
Italfarmaco 50
Not applicableLooking for participantsNCT07263984
What this trial is testing

Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum.

Who this might be right for
Uterine Septum
University Hospital, Ghent 145
Large-scale testing (Phase 3)Study completedNCT00064077
What this trial is testing

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+2 more
Gynecologic Oncology Group 513
Testing effectiveness (Phase 2)Looking for participantsNCT07670312
What this trial is testing

Evaluation of XYA02 in Patients With Advanced Solid Tumors

Who this might be right for
MUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
XYone Therapeutics, Inc 190
Not applicableStudy completedNCT05191212
What this trial is testing

Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial NeoplasmsSentinel Lymph Node Biopsy (SLNB)
Bakirkoy Dr. Sadi Konuk Research and Training Hospital 80
Next Page